Dr. SudheerNeurologist
Conditions

Immune Neuropathy (GBS & CIDP) in New Delhi

Rapid evaluation of Guillain–Barré syndrome, CIDP and autoimmune neuropathies with NCS-guided immunotherapy in New Delhi.

Medically reviewed 2026-08-08 · Dr. Sudheer Pandey, DrNB Neurology

What we offer

  • Urgent triage for rapidly progressive weakness
  • Nerve conduction studies to confirm demyelinating patterns
  • IV immunoglobulin, plasma exchange or steroid pathways
  • Breathing and swallowing monitoring in acute GBS
  • Long-term immunotherapy planning for CIDP

What is immune neuropathy?

Immune neuropathies occur when the immune system attacks peripheral nerves. Guillain–Barré syndrome causes ascending weakness over days; CIDP evolves over weeks and becomes a chronic treatable neuropathy when recognised.

When should I see a neurologist?

Seek urgent neurology care for rapidly worsening walking difficulty, rising numbness, facial weakness, choking or shortness of breath. Waiting for “ordinary neuropathy” medicines can miss a treatable emergency.

How is it diagnosed and treated?

Diagnosis rests on examination, nerve conduction studies and sometimes cerebrospinal fluid analysis. Treatment may include intravenous immunoglobulin, plasma exchange or corticosteroids, chosen for the specific syndrome and severity.

What recovery / prognosis can I expect?

Many patients recover substantial strength with early immunotherapy and physiotherapy. Severe GBS may need weeks in hospital; CIDP often requires ongoing treatment to prevent relapse and preserve walking.

Why see Dr. Sudheer Pandey in New Delhi?

Dr. Sudheer Pandey assesses suspected immune neuropathy at MGS Super Speciality Hospital (Punjabi Bagh) and Shree Aggarsain International Hospital (Rohini) in New Delhi, coordinating hospital therapy when breathing or mobility is threatened.

Frequently Asked Questions

Direct answers to common questions — when to seek care, what to expect, and what to do next.

Yes. GBS can weaken breathing muscles within days. Go to hospital urgently for examination, nerve studies and immunotherapy — early treatment improves the chance of a full motor recovery.

GBS progresses over days and often follows infection. CIDP worsens over at least eight weeks and tends to relapse without maintenance immunotherapy. Both need specialist nerve conduction confirmation.

Intravenous immunoglobulin is a first-line treatment for many GBS and CIDP cases. It supplies immune proteins that modulate the attack on nerves and is given in hospital under monitoring.

Steroids help many CIDP patients but are generally avoided as primary GBS therapy. Your neurologist chooses IVIG, plasma exchange or steroids based on the exact diagnosis and contraindications.

Most patients regain walking with immunotherapy and rehabilitation, though recovery can take months. Severe axonal forms take longer; early physiotherapy and fall prevention remain essential throughout.

GBS is far more often triggered by infections than by vaccines. Discuss personal risk with your neurologist; do not stop recommended immunisations without individualised medical advice.

Hospital teams measure vital capacity and oxygen needs regularly. Progressive respiratory weakness may require intensive care support even before oxygen levels fall — report new shortness of breath immediately.

Many CIDP patients need ongoing IVIG, steroids or other immunotherapy with dose adjustments over time. Planned tapering is possible in some remissions under close neurological follow-up.

Need expert neurology care in New Delhi?

Same-week appointments at MGS Super Speciality Hospital (Punjabi Bagh) and Shree Aggarsain International Hospital (Rohini).

Call Now WhatsApp